Reframing SGLT2 inhibition: Anti-inflammatory mechanisms and drug target insights emerging from EMPA-TROPISM
- DOI
- 10.1016/j.jpet.2026.104945
- Published
- 2026-07
- Container
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jpet.2026.104945,
title = {Reframing SGLT2 inhibition: Anti-inflammatory mechanisms and drug target insights emerging from EMPA-TROPISM},
author = {Ahmed F. El-Yazbi and Reham Fayed and Nefertiti El-Nikhely and Yehia S. Mechref},
year = {2026},
journal = {The Journal of Pharmacology and Experimental Therapeutics},
doi = {10.1016/j.jpet.2026.104945},
url = {https://doi.org/10.1016/j.jpet.2026.104945}
}RIS
TY - JOUR TI - Reframing SGLT2 inhibition: Anti-inflammatory mechanisms and drug target insights emerging from EMPA-TROPISM AU - Ahmed F. El-Yazbi AU - Reham Fayed AU - Nefertiti El-Nikhely AU - Yehia S. Mechref PY - 2026 JO - The Journal of Pharmacology and Experimental Therapeutics DO - 10.1016/j.jpet.2026.104945 UR - https://doi.org/10.1016/j.jpet.2026.104945 ER -
APA
El-Yazbi, A. F., Fayed, R., El-Nikhely, N., & Mechref, Y. S. (2026). Reframing SGLT2 inhibition: Anti-inflammatory mechanisms and drug target insights emerging from EMPA-TROPISM. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/j.jpet.2026.104945
Source records
- crossref · retrieved 2026-09-25T16:16:49.749Z